Report Highlights
The global sample preparation in genomics, proteomics, and epigenomics market should reach $7.4 billion by 2027 from $5.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.4% for the forecast period of 2022 to 2027.
Report Includes
- 71 data tables and 51 additional tables
- Detailed overview and an up-to-date analysis of the global markets for sample preparation devices and consumables in genomics, proteomics, and epigenomics research and applications
- Analyses of the global market trends with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and market forecast for sample preparation instruments and consumables in USD million values, and their corresponding market share analysis by product, application segment, end-user, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
- Review of the recent breakthrough innovations, key technological issues, market regulations, and current status of the intellectual property rights on various instruments and consumables and applications of sample preparation products
- Insight into recent industry structure for the sample preparation market, competitive aspects of each product segments, R&D activities, and major growth strategies adopted in the global market
- Analysis of the competitive environments, new potential markets for novel products and assay developments in the sample preparation industry, and company value share analysis based on their segmental revenues
- Identification of future demand for various sample preparation reagents and products and analysis of target markets
- Descriptive company profiles of the leading global players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Illumina Inc., Merck Millipore, Roche and Thermo Fisher Scientific Inc.
Report Scope
This research report categorizes the market for sample preparation in genomics, proteomics, and epigenomics by product segment. The major product segments are instruments, consumables, accessories, and sample preparation kits. The instruments segment is subdivided into workstations, liquid handling systems, extraction systems, and other instruments. Consumables are divided into columns, filters, tubes, plates, and other consumables. Sample preparation kits are segmented into purification kits, isolation kits, extraction kits, and others.
The global market for sample preparation is segmented by end user into research centers, academic institutes, government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others. The markets in North America, Europe, Asia-Pacific, and Rest of the World (RoW) are covered. The market is also segmented by application into genomics, proteomics, and epigenomics.
Report Synopsis
Report Metrics | Details | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||
Forecast period considered | 2022 to 2027 | ||||||||||||||||
Base year market size | $5.1 billion | ||||||||||||||||
Market size forecast | $7.4 billion | ||||||||||||||||
Growth rate | CAGR of 6.4% for the forecast period of 2022-2027 | ||||||||||||||||
Units considered | $ Millions | ||||||||||||||||
Segments covered | type, instruments, consumable and kits, and region | ||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (ROW) | ||||||||||||||||
Countries covered | U.S., Canada, United Kingdom, France, Denmark, Australia, Japan, China | ||||||||||||||||
Key Market Drivers |
|
||||||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for sample preparation in genomics, proteomics and epigenomics should grow from $6.1 billion in 2019 to $7.8 billion by 2024 at a compound annual growth rate (CAGR) of 5.3% during 2019-2024.
Report Highlights
The global market for sample preparation in genomics, proteomics and epigenomics reached $5.2 billion in 2015. The market should reach $5.6 billion in 2016 and $7.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.5% from 2016 to 2021.
Report Highlights
The global market for sample preparation reagents and products used in life science research reached $4.6 billion in 2012. This market is expected to grow to $5.4 billion in 2013 and then to nearly $11.5 billion in 2018, a compound annual growth rate (CAGR) of 16.3% over the five-year period from 2013 to 2018.
Report Highlights
The global market for sample preparation reagents and products used in life science research was $2.9 billion in 2010, a value expected to increase to $3.6 billion by 2011. This market is forecast to cross $8.4 billion by 2016 increasing at a compound annual growth rate (CAGR) of 18.8%.
Related Reports
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
RNA Sequencing: Technologies and Global Markets
The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.
Global Multiomics Market
The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Recent Reports
2024 Diagnostics Research Review
The Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More